Who
Lisa G. Wolf
COO & CFO
Company insider
Files Form 4 as: COO & CFO, Valion Bio; Chief Accounting Officer, Resonant.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $83K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 14 May 2021
- Last trade
- 18 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 24 Sep 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code M | —4 | filing |
| 18 Sep 2026filed 24 Sep 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code F | $42 at $2.12 | filing |
| 18 Sep 2026filed 24 Sep 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —4 at $0.00 | filing |
| 18 Sep 2026filed 24 Sep 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —4 at $0.00 | filing |
| 18 Sep 2026filed 24 Sep 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code M | —4 | filing |
| 18 Sep 2026filed 24 Sep 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code F | $42 at $2.12 | filing |
| 18 Jun 2026filed 18 Jun 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code M | —92 | filing |
| 18 Jun 2026filed 18 Jun 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —92 at $0.00 | filing |
| 18 Jun 2026filed 18 Jun 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —92 at $0.00 | filing |
| 18 Jun 2026filed 18 Jun 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code M | —92 | filing |
| 18 Mar 2026filed 19 Mar 2026 | Tivic Health SystemsBiotechnology | SEC FORM 4 Code M | —92 | filing |
| 18 Mar 2026filed 19 Mar 2026 | Tivic Health Systemsoption or derivative · Biotechnology | SEC FORM 4 Code M | —92 at $0.00 | filing |
| 18 Mar 2026filed 19 Mar 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —92 at $0.00 | filing |
| 18 Mar 2026filed 19 Mar 2026 | VBIO Valion BioBiotechnology | SEC FORM 4 Code M | —92 | filing |
| 18 Dec 2025filed 22 Dec 2025 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —736 at $0.00 | filing |
| 18 Dec 2025filed 22 Dec 2025 | VBIO Valion BioBiotechnology | SEC FORM 4 Code M | —736 | filing |
| 18 Dec 2025filed 22 Dec 2025 | VBIO Valion BioBiotechnology | SEC FORM 4 Code F | $565302 at $1.87 | filing |
| 6 Aug 2025filed 22 Aug 2025 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 6 Aug 2025filed 8 Aug 2025 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 18 Dec 2024filed 20 Dec 2024 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.